sr141716 has been researched along with hu 308 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almehizia, AA; Alqarni, MH; Bartlow, P; Cao, H; Cheng, T; Feng, R; Gao, Y; Gertsch, J; Kurihara, N; Myint, KZ; Roodman, GD; Teramachi, J; Tong, Q; Wang, L; Xie, XQ; Yang, P | 1 |
| Almehizia, AA; Alqarni, MH; Feng, R; Myint, KZ; Ouyang, Q; Tong, Q; Wang, L; Xie, XQ; Yang, P | 1 |
| Breuer, A; Fride, E; Goldenberg, D; Hanus, L; Horowitz, M; Mechoulam, R; Pertwee, RG; Ross, RA; Shiloah, S; Tchilibon, S | 1 |
| Buettner, R; Cravatt, B; Date, R; Di Marzo, V; Gaffal, E; Karsak, M; Mechoulam, R; Petrosino, S; Rehnelt, J; Schlicker, E; Starowicz, K; Steuder, R; Tüting, T; Wang-Eckhardt, L; Werner, S; Zimmer, A | 1 |
| Feng, R; Milcarek, CA; Xie, XQ | 1 |
| Crews, FT; Grant, ML; Jones, VM; Khatri, D; Laroche, G; Mukhopadhyay, S; Vetreno, RP | 1 |
6 other study(ies) available for sr141716 and hu 308
| Article | Year |
|---|---|
Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors.
Topics: Alkylation; Animals; Benzeneacetamides; Binding, Competitive; Bone Marrow; Cell Death; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Osteoclasts; Osteogenesis; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2012 |
Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation.
Topics: Animals; Biological Assay; Cannabinoid Receptor Agonists; CHO Cells; Cricetinae; Ligands; Macrophages; Mice; Osteoclasts; Quantitative Structure-Activity Relationship; Receptor, Cannabinoid, CB2; Sulfonamides | 2013 |
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.
Topics: Analgesics; Animals; Arachidonic Acid; Blood Pressure; Camphanes; Cannabinoids; Cyclic AMP; Female; Mice; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Structure-Activity Relationship | 1999 |
Attenuation of allergic contact dermatitis through the endocannabinoid system.
Topics: Animals; Arachidonic Acids; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Chemokines; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Down-Regulation; Dronabinol; Endocannabinoids; Female; Glycerides; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Skin; Up-Regulation | 2007 |
Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.
Topics: Camphanes; Cannabinoids; Cell Line; Cell Proliferation; DNA-Binding Proteins; Humans; Immunoglobulin M; Indoles; Interleukin-6; PAX5 Transcription Factor; Piperidines; Proto-Oncogene Proteins c-bcl-6; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; STAT3 Transcription Factor | 2014 |
Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling.
Topics: Animals; Binge Drinking; Cannabinoids; Carbamates; Caspase 3; Cell Death; Cell Proliferation; Doublecortin Domain Proteins; Doublecortin Protein; Drug Interactions; Endocannabinoids; Ethanol; Hippocampus; Ki-67 Antigen; Male; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Piperazines; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2018 |